NPC Archive Item: Restrictions on the import of unlicensed melatonin products

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. MHRA drug procurement advice: Restrictions on the import of unlicensed melatonin products following marketing authorisation for Circadin®▼2mg tablets. 15th August 2008. A licensed melatonin product, (Circadin®▼ 2mg tablets) became […]

NPC Archive Item: Cases of lung cancer reported in clinical trials of inhaled insulin (Exubera®▼)

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. http://www.fda.gov/medwatch/safety/2008/safety08.htm#exubera The FDA in America has issued a Dear Healthcare Professional letter regarding cases of lung cancer in clinical trials and during post-marketing surveillance in patients treated with Pfizer’s […]

NPC Archive Item: Vildagliptin launched in UK

NOTE – This is an archive post from the NPC and has not been updated since first publication. Therefore, some hyperlinks may no longer be working. Vildagliptin▼(Galvus ®), a dipeptidyl peptidase type 4 (DPP-4) inhibitor and vildagliptin/metformin▼ (Eucreas®) have recently been launched in the UK. Vildagliptin is licensed for the treatment of type 2 diabetes […]